The phase 2b REZOLVE-AD trial enrolled 393 adults with moderate-to-severe atopic dermatitis across approximately 110 global ...
If you’re a person of color, finding the right treatment for atopic dermatitis, a common form of eczema, can be challenging. Even though the disease is more prevalent in Black Americans than white ...
Recently published Atopic Dermatitis Market Insights report includes a comprehensive understanding of current treatment ...
Atopic dermatitis is associated with increased asthma and rhinitis worldwide, according to new global estimates. Learn more.
The core symptoms of atopic dermatitis — dry and cracked skin, itchiness, rashes on swollen skin, and oozing, crusting irritated skin — can appear anywhere on the body. The exact symptoms and severity ...
The FDA has approved topical difamilast for treating mild-to-moderate atopic dermatitis (AD) in adults and children aged 2 years or older, according to a press release from the manufacturer, Acrotech ...
Researchers have found in a new study that there is no general association between atopic dermatitis (AD) and contact ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Both children and adults with atopic dermatitis have an increased risk of inflammatory bowel disease (IBD), according to a population-based cohort study. In fully adjusted models, kids with atopic ...
Atopic dermatitis is a chronic (long-lasting) skin condition that causes dry, itchy patches of skin that may crack or ooze. It is the most common form of eczema. Itchiness occurs when an overactive ...
Adults with atopic dermatitis and chronic hand eczema saw early and sustained improvements in skin and quality of life measures with tralokinumab compared with placebo, according to a poster presented ...
Apogee Therapeutics develops biologic therapies targeting dermatology and respiratory conditions, with lead candidates in clinical trials.